Niraparib Efficacy unResectable MesotheliOma Trial recently launched in Glasgow

Posted by: NNs - Posted on:

NERO – Niraparib Efficacy in patients with unResectable MesotheliOma is a randomised phase II trial of Niraparib versus
active symptom control in patients with previously treated mesothelioma recently opened in Glasgow. For more information or to refer a patient please contact Dr Nicola Steel, Consultant in Medical Oncology via the Beatson West of Scotland Cancer Centre.